129 related articles for article (PubMed ID: 30678426)
21. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
22. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-κB pathway in ovarian cancer.
Gai M; Bo Q; Qi L
Biochem Biophys Res Commun; 2016 Jan; 469(4):1000-5. PubMed ID: 26713367
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
25. Screening candidate genes associated with bladder cancer using DNA microarray.
Xu A; Wang C; Sun S
Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of focal adhesion signaling in response to cyclophilin A knockdown in human endometrial cancer cells, implicated by cDNA microarray analysis.
Li Z; Gou J; Xu J
Gynecol Oncol; 2013 Oct; 131(1):191-7. PubMed ID: 23899654
[TBL] [Abstract][Full Text] [Related]
27. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y
Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214
[TBL] [Abstract][Full Text] [Related]
28. Identification of genes associated with lung cancer by bioinformatics analysis.
Li J; Yu H; Ma YF; Zhao M; Tang J
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2397-2404. PubMed ID: 28617549
[TBL] [Abstract][Full Text] [Related]
29. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
30. MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses.
Shi L; Zhao SM; Luo Y; Zhang AW; Wei LH; Xie ZY; Li YY; Ma W
Pathol Res Pract; 2017 Nov; 213(11):1344-1354. PubMed ID: 29033189
[TBL] [Abstract][Full Text] [Related]
31. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
Zhang M; Luo SC
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining.
Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G
Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854
[TBL] [Abstract][Full Text] [Related]
34. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
Ruan L; Xie Y; Liu F; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
[TBL] [Abstract][Full Text] [Related]
35. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations following ionizing radiation in human ovarian cancer-derived endothelial cells.
Liu T; Du X; Sheng X
Mol Med Rep; 2014 Jun; 9(6):2257-64. PubMed ID: 24691555
[TBL] [Abstract][Full Text] [Related]
37. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
Wang G; Zhang Z; Ren Y
Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
[TBL] [Abstract][Full Text] [Related]
38. Convergence and divergence of genetic and modular networks between diabetes and breast cancer.
Zhang X; Zhang Y; Yu Y; Liu J; Yuan Y; Zhao Y; Li H; Wang J; Wang Z
J Cell Mol Med; 2015 May; 19(5):1094-102. PubMed ID: 25752479
[TBL] [Abstract][Full Text] [Related]
39. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatics Analysis of Key Genes and Pathways for Medulloblastoma as a Therapeutic Target.
Shaabanpour Aghamaleki F; Mollashahi B; Aghamohammadi N; Rostami N; Mazloumi Z; Mirzaei H; Moradi A; Sheikhpour M; Movafagh A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):221-227. PubMed ID: 30678435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
